In the second quarter, we saw notable growth particularly in our medical systems for drug delivery and in pharmaceutical plastic packaging. Our latest acquisitions in India are also developing very well,” said Uwe Röhrhoff, CEO of Gerresheimer AG.
Gerresheimer increased revenues in the second quarter of financial year 2013 (financial year from December 1 to November 30) by 4.2% to EUR 327.1m. The revenue growth mainly reflects strong business in the Plastic Systems Division with pharmaceutical primary packaging, insulin pens and inhalers. Triveni, an Indian company specializing in pharmaceutical plastic packaging acquired in December 2012, likewise contributed to the increase in revenues. The Moulded Glass Division generated healthy growth rates notably with the sale of cosmetic glass packaging.
Read more here.
Solid second quarter 2013 for Gerresheimer
Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, generated solid figures in the second quarter of the 2013 financial year. -Second-quarter revenues up 4.2% to EUR 327.1m -Adjusted EBITDA of EUR 59.8m slightly above prior-year quarter (up 0.5%)-Adjusted net income at EUR 21.5m (up 0.9%)-Adjusted earnings per share on a par with prior-year quarter, at EUR 0.63 -Guidance for financial year 2013 made more specific “Our strategy is geared to sustained, profitable growth.We continue to be successful in implementing that strategy.